Exporter India Sorafenat 200mg Tablet (Sorafenib Tosylate)| Bulk Supply Oncology Drugs .
Buy Sorafenat 200mg Tablet (Sorafenib Tosylate) in bulk from India. Leading oncology drug exporter City Drug House Exporters offering global supply with latest regulatory updates and competitive pricing.
Pharmacological Class & Mechanism
Active Ingredient: Sorafenib Tosylate (200 mg)
Therapeutic Class: Antineoplastic Agent
Action Class: Multikinase Inhibitor / Tyrosine Kinase Inhibitor (TKI)
Mechanism of Action:
Targets intracellular RAF/MEK/ERK signaling pathway.
Targets cell surface kinases (VEGFR-2, VEGFR-3, PDGFR-beta).
Inhibits tumor angiogenesis (new blood vessel formation) and cell proliferation (apoptosis regulation).
Chemical Class: Diarylether derivative .
Key Pharmacology Tags :
Antineoplastic/Oncology (Kidney, Liver, Thyroid)
Multikinase Inhibitor/TKI
Angiogenesis Inhibitor
Oral Administration (Empty stomach recommended: 1 hour before or 2 hours after food)
Hand-Foot Skin Reaction (Common side effect)
Teratogenic/Embryotoxic (Contraception required for both males and females)
Cardiovascular Risks (Hypertension, Cardiac Ischemia/Infarction, QT Prolongation)
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA, Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Buy Sorafenat 200mg Tablet (Sorafenib Tosylate) in bulk from India. Leading oncology drug exporter City Drug House Exporters offering global supply with latest regulatory updates and competitive pricing.
Pharmacological Class & Mechanism
Active Ingredient: Sorafenib Tosylate (200 mg)
Therapeutic Class: Antineoplastic Agent
Action Class: Multikinase Inhibitor / Tyrosine Kinase Inhibitor (TKI)
Mechanism of Action:
Targets intracellular RAF/MEK/ERK signaling pathway.
Targets cell surface kinases (VEGFR-2, VEGFR-3, PDGFR-beta).
Inhibits tumor angiogenesis (new blood vessel formation) and cell proliferation (apoptosis regulation).
Chemical Class: Diarylether derivative .
Key Pharmacology Tags :
Antineoplastic/Oncology (Kidney, Liver, Thyroid)
Multikinase Inhibitor/TKI
Angiogenesis Inhibitor
Oral Administration (Empty stomach recommended: 1 hour before or 2 hours after food)
Hand-Foot Skin Reaction (Common side effect)
Teratogenic/Embryotoxic (Contraception required for both males and females)
Cardiovascular Risks (Hypertension, Cardiac Ischemia/Infarction, QT Prolongation)
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA, Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
